Aldeyra Therapeutics Statistics
Total Valuation
ALDX has a market cap or net worth of $283.46 million. The enterprise value is $226.33 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, after market close.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ALDX has 59.55 million shares outstanding. The number of shares has increased by 1.03% in one year.
| Current Share Class | 59.55M |
| Shares Outstanding | 59.55M |
| Shares Change (YoY) | +1.03% |
| Shares Change (QoQ) | +0.19% |
| Owned by Insiders (%) | 2.58% |
| Owned by Institutions (%) | 37.26% |
| Float | 43.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 9.78 |
| PB Ratio | 3.33 |
| P/TBV Ratio | 3.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.80, with a Debt / Equity ratio of 0.18.
| Current Ratio | 6.80 |
| Quick Ratio | 4.24 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -25.20 |
Financial Efficiency
Return on equity (ROE) is -43.05% and return on invested capital (ROIC) is -25.86%.
| Return on Equity (ROE) | -43.05% |
| Return on Assets (ROA) | -23.45% |
| Return on Capital (ROIC) | -25.86% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.48M |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +67.02% in the last 52 weeks. The beta is 1.43, so ALDX's price volatility has been higher than the market average.
| Beta (5Y) | 1.43 |
| 52-Week Price Change | +67.02% |
| 50-Day Moving Average | 5.37 |
| 200-Day Moving Average | 4.33 |
| Relative Strength Index (RSI) | 43.62 |
| Average Volume (20 Days) | 549,360 |
Short Selling Information
The latest short interest is 3.67 million, so 6.16% of the outstanding shares have been sold short.
| Short Interest | 3.67M |
| Short Previous Month | 3.40M |
| Short % of Shares Out | 6.16% |
| Short % of Float | 8.48% |
| Short Ratio (days to cover) | 8.67 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -49.64M |
| Pretax Income | -37.87M |
| Net Income | -44.80M |
| EBITDA | -49.39M |
| EBIT | -49.64M |
| Earnings Per Share (EPS) | -$0.75 |
Full Income StatementBalance Sheet
The company has $72.74 million in cash and $15.61 million in debt, giving a net cash position of $57.13 million or $0.96 per share.
| Cash & Cash Equivalents | 72.74M |
| Total Debt | 15.61M |
| Net Cash | 57.13M |
| Net Cash Per Share | $0.96 |
| Equity (Book Value) | 85.10M |
| Book Value Per Share | 1.43 |
| Working Capital | 99.57M |
Full Balance SheetCash Flow
| Operating Cash Flow | -30.67M |
| Capital Expenditures | n/a |
| Free Cash Flow | -30.67M |
| FCF Per Share | -$0.52 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |